Roche Molecular Systems, Inc.
4300 Hacienda Drive
Roche Molecular Diagnostics (operating in the US as Roche Molecular Systems) develops, manufactures and supplies a wide array of innovative medical diagnostic products, services, tests, platforms and technologies. With its broad portfolio of oncology, virology, microbiology and blood screening tests, RMD’s clients include researchers, physicians, patients, hospitals, laboratories and blood banks around the world.
The business, headquartered in Pleasanton, California, was founded in the early 1990s following the acquisition of the revolutionary, Nobel-prize winning Polymerase Chain Reaction Technology (PCR). PCR quickly replicates a single specific fragment of DNA or RNA to quantities sufficient for accurate laboratory analysis.
Roche Molecular Diagnostics employs around around 1,400 people across five locations: Pleasanton, California; Los Gatos, California; Branchburg, New Jersey; Marlborough, Massachusetts; and Rotkreuz, Switzerland.
Centers of Excellence for Roche Molecular Systems
Branchburg (US): The largest polymerase chain reaction (PCR) manufacturing site in the world, supply chain, global customer support and quality
Los Gatos (US): Newest location that focuses on microbiology diagnostics
Marlborough (US): Center for RMD’s Point of Care business
Pleasanton (US): Headquarters, R&D, regulatory, clinical and medical affairs, business marketing and strategic marketing support
Rotkreuz (CH): Development and production of systems (instruments) and lab network solutions (software)
Roche Molecular Systems